Journal of Parkinson s DiseaseNeurosciencePeer-reviewed journal article
An assessment of LRRK2 serine 935 phosphorylation in human peripheral blood mononuclear cells in idiopathic Parkinson’s disease and G2019S LRRK2 cohorts
Shalini PadmanabhaniD, Thomas A. LanziD, Donal N. GormaniD, Michele Wolfe, Alison P. Joyce, Carlos Cabrera, Rosemary F. Lawrence-Henderson, Najah Levers, Neal Joshi, Thong Chi MaiD, Christopher Liong, Sushma Narayan, Roy N. AlcalayiD, Samantha J. HutteniD, Marco A. S. BaptistaiD, Kalpana MerchantiD
Abstract
The phosphorylated form of LRRK2, pS935 LRRK2, has been proposed as a target modulation biomarker for LRRK2 inhibitors. To qualify the biomarker for therapeutic trials, we assessed pS935 LRRK2 levels in Peripheral Blood Mononuclear Cells (PBMCs). Analyses of PBMCs from healthy controls, idiopathic Parkinsons disease (iPD), and G2019S carriers with and without PD showed significant reductions in pS935 LRRK2 levels normalized to total LRRK2 levels in G2019S carriers with PD compared to those without PD or iPD. Neither analyte correlated with age, gender, or disease severity. Thus, pS935 LRRK2 in PBMCs may reflect a state marker for G2019S LRRK2-driven PD.
- Citations
- 46
- FWCI
- 3.46
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A potential patient stratification biomarker for Parkinson's disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, … Sabine Hilfiker·bioRxiv·Apr 11, 2023
- Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10
Xiang Wang, Elvira Negrou, … Anastasia G. Henry·Scientific ReportsPeer-reviewed·Jun 18, 2021
- Accurate MS-based Rab10 phosphorylation stoichiometry determination as readout for LRRK2 activity in Parkinson’s disease
O. Karayel, F. Tonelli, … M. Mann·bioRxiv·Oct 25, 2019
- Distinct profiles of LRRK2 activation and Rab GTPase phosphorylation in clinical samples from different PD cohorts
Lilian Petropoulou-Vathi, Athina‐Maria Simitsi, … Hardy J. Rideout·npj Parkinson s DiseasePeer-reviewed·Jun 8, 2022
- Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation
Yuan Yuan, Huizhong Li, … Andrew B. West·Molecular NeurodegenerationPeer-reviewed·Jun 11, 2024
- Dopaminergic Neurodegeneration Induced by Parkinson's Disease-Linked G2019S LRRK2 is Dependent on Kinase and GTPase Activity
An Phu Tran Nguyen, Elpida Tsika, … Darren J. Moore·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 6, 2020